Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients.

Alirezaei, Amirhesam; Jamshidi Fard, Ali; Argani, Hasan; Talaie, Ramin; Nooraninia, Sahar; Iranshahi, Majid; Darvish, Parichehr

Alirezaei, Amirhesam; Jamshidi Fard, Ali; Argani, Hasan; Talaie, Ramin; Nooraninia, Sahar; Iranshahi, Majid; Darvish, Parichehr.

Affiliation

Jamshidi Fard A; Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. alijamshidifard@gmail.com.

Iran J Kidney Dis ; 11(3): 237-240, 2017 May.

Article in En | MEDLINE | ID: mdl-28575885

Subject(s)

Clarithromycin/therapeutic use; Helicobacter Infections/drug therapy; Helicobacter pylori/drug effects; Levofloxacin/therapeutic use; Renal Dialysis; Uremia/therapy; Adult; Antigens, Bacterial/metabolism; Clarithromycin/adverse effects; Double-Blind Method; Feces/microbiology; Female; Helicobacter Infections/diagnosis; Helicobacter Infections/microbiology; Helicobacter pylori/growth & development; Helicobacter pylori/metabolism; Humans; Iran; Levofloxacin/adverse effects; Male; Middle Aged; Time Factors; Treatment Outcome; Uremia/diagnosis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uremia / Helicobacter pylori / Helicobacter Infections / Renal Dialysis / Clarithromycin / Levofloxacin Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Iran J Kidney Dis Journal subject: NEFROLOGIA Year: 2017 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links